Survival Benefit of Stereotactic Radiotherapy in the Complex Management of Metastatic Melanoma.

Background/aim: Targeted therapy and immunotherapy, with additional stereotactic radiation therapy (SRT) have revolutionized the management of metastatic malignant melanoma (mMM). We aimed to analyze the effectiveness and safety of SRT and determine its role in the complex management of mMM.

Patients And Methods: We treated 24 patients with solitary metastasis, 15 with oligometastatic disease and one with multiple metastases.